April 6, 2017 / 12:22 PM / 8 months ago

BRIEF-Steadymed announces successful completion of trevyent clinical validation study

April 6 (Reuters) - Cardiome Pharma Corp:

* Cardiome’s partner steadymed announces successful completion of trevyent clinical validation study

* Cardiome Pharma-Steadymed says results “indicate patchpump devices performed as intended in all categories of evaluation”, including dose accuracy, precision Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below